# Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma

> **NCT01805453** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 80 (actual)

## Conditions studied

- Newly-diagnosed Glioblastoma

## Interventions

- **DRUG:** Losartan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01805453
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-29
- **Primary completion:** 2015-01-15
- **Final completion:** 2017-05-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01805453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01805453, "Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01805453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*